Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies.

Raleigh Ayoolu FatokiKelly KoehnAmar H Kelkar Samer Al HadidiNikita MehraHira S Mian Carl Ola Landgren Dickran KazandjianJames HoffmanDouglas W SborovGhulam Rehman Mohyuddin

Published in: JCO global oncology (2022)

There are substantial disparities in where novel therapies are evaluated and where they are ultimately approved for use on the basis of income level and geography.

Keyphrases

physical activity
study protocol
clinical trial
phase iii
multiple myeloma
mental health
phase ii
emergency department
healthcare
drug administration
adverse drug
drug induced